Table of Content

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Potential) – United States Proton Therapy Market (2009 – 2025)

4.1 Actual Proton Therapy Market
4.2 Potential Proton Therapy Market


5. Number of Patients – United States Proton Therapy (2009 – 2025)

5.1 Actual Numbers
5.2 Potential Numbers


6. Cancer Types – Patients Number in United States Proton Therapy (2009 – 2025)

6.1 Central Nervous System Tumors
6.2 Intraocular Melanomas Cancer
6.3 Pituitary Neoplasms Cancer
6.4 Base of Skull / Axial Skeleton Cancer
6.5 Head and Neck Cancer
6.6 Lung Cancer
6.7 Retroperitoneal Sarcoma Cancer
6.8 Pediatric Cancer Cases (Up to Age 18)
6.9 Gastrointestinal Tract Cancer
6.10 Urinary Tract Cancer
6.11 By Female Pelvic Organs Cancer
6.12 Prostate Cancer
6.13 Breast Cancer
6.14 Other Cancer


7. Cancer Types – United States Proton Therapy Market (2009 – 2025)

7.1 Central Nervous System Tumors
7.2 Intraocular Melanomas Cancer
7.3 Pituitary Neoplasms Cancer
7.4 Base of Skull / Axial Skeleton Cancer
7.5 Head and Neck Cancer
7.6 Lung Cancer
7.7 Retroperitoneal Sarcoma Cancer
7.8 Pediatric Cancer (Up to Age 18)
7.9 Gastrointestinal Tract Cancer
7.10 Urinary Tract Cancer
7.11 Female Pelvic Organs Cancer
7.12 Prostate Cancer
7.13 Breast Cancer
7.14 Other Cancer


8. United States – List of Proton Therapy Centers

8.1 Operating Proton Therapy Centers
8.2 Under-Construction Therapy Centers
8.3 Planning Proton Therapy Centers


9. By Centers – Number of Proton Therapy Patients Treated

9.1 Loma Linda (LLUMC) Proton Therapy Center (2008 – 2016)
9.2 UCSF – CNL Proton Therapy Center (2008 – 2015)
9.3 Boston (NPTC) Proton Therapy Center (2008 – 2016)
9.4 Bloomington (MPRI, 2) Proton Therapy Center (2008 – 2014)
9.5 Houston (MD Anderson) Proton Therapy Center (2008 – 2016)
9.6 UFPTI Jacksonville Proton Therapy Center (2008 – 2016)
9.7 Oklahoma City (ProCure PTC) Proton Therapy Center (2009 – 2017)
9.8 CDH Warrenville Proton Therapy Center (2010 – 2016)
9.9 Philadelphia (Upenn) Proton Therapy Center (2011 – 2016)
9.10 Hampton (HUPTI) Proton Therapy Center (2012 – 2016)
9.11 New Jersey (ProCure PTC) Proton Therapy Center (2012 – 2016)
9.12 Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 – 2016)
9.13 St. Louis (S. Lee King PTC) Proton Therapy Center (2013 – 2016)
9.14 Provision Center for Proton Therapy, Knoxville, TN (2014 – 2016)
9.15 San Diego (Scripps PTC) (2014 – 2017)
9.16 Shreveport (Willis Knighton) Proton Therapy Center (2014 – 2017)
9.17 Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
9.18 Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
9.19 Brunswick (Laurie PC) Proton Therapy Center (2015)
9.20 Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
9.21 Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
9.22 Phoenix (Mayo PBTC) Proton Therapy Center (2016)
9.23 Baltimore (Maryland PTC) Proton Therapy Center (2016)
9.24 Cincinnati (Children’s PTC) Proton Therapy Center (2016)
9.25 Orlando (Orlando Health PTC) Proton Therapy Center (2016)
9.26 Cleveland (UH Sideman PTC) Proton Therapy Center (2016)


10. Proton Therapy – Reimbursement Policies

10.1 Proton Therapy Reimbursement Policies for Patients
10.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers


11. Components of a Standard Proton Therapy Center

11.1 Proton Accelerator

11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (Rome)
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Super-conducting Cyclotrons
11.1.8 Fast Cycling Synchrotron

11.2 Beam Transport System
11.3 Beam Delivery System

11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning

11.4 Nozzle

11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle

11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource


12. Company Analysis (2014 – 2025)

12.1 IBA Proton Therapy

12.1.1 Sales Analysis

12.2 Varian Medical Systems

10.2.2 Sales Analysis

12.3 Elekta

12.3.1 Sales Analysis


13. Driving Factors

13.1 Technology Advancement

13.1.1 Next-Generation Proton Technique

13.2 Growing Incidence of Cancer Patients in United States


14. Challenges

14.1 Requires Huge Investment
14.2 Operations Challenges



List of Figures



Figure 2 1: United States – Proton Therapy Market (Million US$), 2009 – 2018
Figure 2 2: United States – Forecast for Proton Therapy Market (Million US$), 2019 – 2025
Figure 2 3: United States – Potential Proton Therapy Market (Million US$), 2009 – 2018
Figure 2 4: United States – Forecast for Potential Proton Therapy Market (Million US$), 2019 – 2025
Figure 3 1: United States – Patient Treated with Proton Therapy (Number), 2009 – 2018
Figure 3 2: United States – Forecast for Patient Treated with Proton Therapy (Number), 2019 – 2025
Figure 3 3: United States – Potential Candidate for Proton Therapy (Number), 2009 – 2018
Figure 3 4: United States – Forecast for Potential Candidate for Proton Therapy (Number), 2019 – 2025
Figure 4 1: United States – Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 – 2018
Figure 4 2: United States – Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2019 – 2025
Figure 4 3: United States – Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 – 2018
Figure 4 4: United States – Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2019 – 2025
Figure 4 5: United States – Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 – 2018
Figure 4 6: United States – Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2019 – 2025
Figure 4 7: United States – Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 – 2018
Figure 4 8: United States – Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2019 – 2025
Figure 4 9: United States – Proton Therapy Patient by Head and Neck Cancer (Number), 2009 – 2018
Figure 4 10: United States – Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2019 – 2025
Figure 4 11: United States – Proton Therapy Patient by Lung Cancer (Number), 2009 – 2018
Figure 4 12: United States – Forecast for Proton Therapy Patient by Lung Cancer (Number), 2019 – 2025
Figure 4 13: United States – Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 – 2018
Figure 4 14: United States – Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2019 – 2025
Figure 4 15: United States – Proton Therapy Patient by Pediatric Cancer (Number), 2009 – 2018
Figure 4 16: United States – Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2019 – 2025
Figure 4 17: United States – Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 – 2018
Figure 4 18: United States – Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2019 – 2025
Figure 4 19: United States – Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 – 2018
Figure 4 20: United States – Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2019 – 2025
Figure 4 21: United States – Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 – 2018
Figure 4 22: United States – Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2019 – 2025
Figure 4 23: United States – Proton Therapy Patient by Prostate Cancer (Number), 2009 – 2018
Figure 4 24: United States – Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2019 – 2025
Figure 4 25: United States – Proton Therapy Patient by Breast Cancer (Number), 2009 – 2017
Figure 4 26: United States – Forecast for Proton Therapy Patient by Breast Cancer (Number), 2019 – 2025
Figure 4 27: United States – Proton Therapy Patient by Other Cancer (Number), 2009 – 2018
Figure 4 28: United States – Forecast for Proton Therapy Patient by Other Cancer (Number), 2019 – 2025
Figure 5 1: United States – Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 – 2018
Figure 5 2: United States – Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2019 – 2025
Figure 5 3: United States – Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 – 2018
Figure 5 4: United States – Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2019 – 2025
Figure 5 5: United States – Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 – 2018
Figure 5 6: United States – Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2019 – 2025
Figure 5 7: United States – Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 – 2018
Figure 5 8: United States – Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2019 – 2025
Figure 5 9: United States – Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 – 2018
Figure 5 10: United States – Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 – 2025
Figure 5 11: United States – Proton Therapy Market by Lung Cancer (Million US$), 2009 – 2018
Figure 5 12: United States – Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 – 2025
Figure 5 13: United States – Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 – 2018
Figure 5 14: United States – Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2019 – 2025
Figure 5 15: United States – Proton Therapy Market by Pediatric Cancer (Million US$), 2009 – 2018
Figure 5 16: United States – Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2019 – 2025
Figure 5 17: United States – Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 – 2018
Figure 5 18: United States – Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2019 – 2025
Figure 5 19: United States – Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 – 2018
Figure 5 20: United States – Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2019 – 2025
Figure 5 21: United States – Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 – 2018
Figure 5 22: United States – Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2019 – 2025
Figure 5 23: United States – Proton Therapy Market by Prostate Cancer (Million US$), 2009 – 2018
Figure 5 24: United States – Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2019 – 2025
Figure 5 25: United States – Proton Therapy Market by Breast Cancer (Million US$), 2009 – 2018
Figure 5 26: United States – Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2019 – 2025
Figure 5 27: United States – Proton Therapy Market by Other Cancer (Million US$), 2009 – 2018
Figure 5 28: United States – Forecast for Proton Therapy Market by Other Cancer (Million US$), 2019 – 2025
Figure 10 1: Global – IBA Proton Therapy Sales (Million US$), 2014 – 2018
Figure 10 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2019 – 2025
Figure 10 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2014 – 2018
Figure 10 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2019 – 2025
Figure 10 5: Global – Elekta Revenue, (Million USD), 2014 – 2018
Figure 10 6: Global – Forecast for Elekta Revenue, (Million US$), 2019 – 2025
Figure 11 1: United States – Numbers of Patient Diagnosed With cancer (In Number), 2014 – 2018
Figure 11 2: United States – Forecast for Numbers of Patient Diagnosed With cancer (In Number), 2019 – 2025

 

List of Tables


N/A